Fanconi anemia with biallelic FANCD1/BRCA2 mutations – Case report of a family with three affected children
- 1 March 2016
- journal article
- case report
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 59 (3) , 152-157
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Czech Republic (00064203)
- University Hospital Motol, Prague, Czech Republic (MZO VFN 0064165)
- General Teaching Hospital Prague (NF-CZ11-PDP-3-003-2014)
This publication has 24 references indexed in Scilit:
- VACTERL-H Association and Fanconi AnemiaMolecular Syndromology, 2012
- Molecular pathogenesis and clinical management of Fanconi anemiaJournal of Clinical Investigation, 2012
- Gene Therapy for Fanconi Anemia: One Step Closer to the ClinicHuman Gene Therapy, 2012
- Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histologyNeuro-Oncology, 2011
- Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumorPediatric Blood & Cancer, 2009
- BRCA in breast cancer: ESMO Clinical RecommendationsAnnals of Oncology, 2009
- Fanconi Anemia: Fanconi anemia, breast and embryonal cancer risk revisitedEuropean Journal of Human Genetics, 2007
- Fanconi anaemia genes and susceptibility to cancerOncogene, 2006
- Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2Journal of Medical Genetics, 2006
- Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumourJournal of Medical Genetics, 2005